PrEP users have less HIV anxiety
One-third of people living with HIV in rural Tanzania report clinically relevant drug-drug interactions
Serosorting between gay men may be in decline as ‘PrEP sorting’ rises, Canadian study finds
Rates of pneumonia and pneumococcal disease remain high among people with HIV
Hepatitis C incidence is low among Canadian men on PrEP
How do we deal with apparent cases of PrEP failure?
96-week results of DISCOVER PrEP trial presented at European AIDS Conference
Options for two-drug simplification expand
Tenofovir (TDF) does not increase risk of kidney disease in people at low risk
